The Paradigm Shifts in the Management of Breast Cancer-have We Finally Arrived?
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer.
AlSumai T, Alhazzaa N, Alshamrani A, Assiri S, Alhefdhi A Breast Cancer (Dove Med Press). 2022; 14:323-334.
PMID: 36237483 PMC: 9553108. DOI: 10.2147/BCTT.S373005.
Ten commandments of safe and optimum mastectomy for breast cancer.
Chintamani Indian J Surg. 2014; 76(3):175-80.
PMID: 25177112 PMC: 4141050. DOI: 10.1007/s12262-014-1120-8.
References
1.
Fisher E, Anderson S, Tan-Chiu E, Fisher B, Eaton L, Wolmark N
. Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06. Cancer. 2001; 91(8 Suppl):1679-87.
View
2.
Chintamani , Tandon M, Mishra A, Agarwal U, Saxena S
. Sentinel lymph node biopsy using dye alone method is reliable and accurate even after neo-adjuvant chemotherapy in locally advanced breast cancer--a prospective study. World J Surg Oncol. 2011; 9:19.
PMC: 3041688.
DOI: 10.1186/1477-7819-9-19.
View
3.
Chintamani , Rekhi B, Bansal A, Bhatnagar D, Saxena S
. Expression of E-Cadherin in breast carcinomas and its association with other biological markers - a prospective study. Indian J Surg Oncol. 2012; 1(1):40-6.
PMC: 3420990.
DOI: 10.1007/s13193-010-0010-1.
View
4.
Chintamani , Kulshreshtha P, Chakraborty A, Singh L, Mishra A, Bhatnagar D
. Androgen receptor status predicts response to chemotherapy, not risk of breast cancer in Indian women. World J Surg Oncol. 2010; 8:64.
PMC: 2922205.
DOI: 10.1186/1477-7819-8-64.
View
5.
Mishra A, Agrawal U, Negi S, Bansal A, Mohil R, Chintamani C
. Expression of androgen receptor in breast cancer & its correlation with other steroid receptors & growth factors. Indian J Med Res. 2012; 135(6):843-52.
PMC: 3410212.
View